![]() |
|
|
|
|
#1 | ||||
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Quote:
Quote:
Quote:
Quote:
|
||||
|
|
|
|
|
#2 | ||
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
Quote:
Second, it was not a "counterpart" to the human studies because there have been no human safety studies with the Hepatitis B vaccination, nor most of the other vaccinations on the infant schedule, nor any combination of them together. There was one study that linked a particular brand of Hepatitis B vaccine to an increased risk of a non-autistic neurological disorder, but that would put the monkey study on the same side as the human studies, not a counterpart. Third, I didn't realize that our purposes at this moment were still on thimerosal. I'm not sure based on your comment if you do realize that the Hepatitis B vaccine gave developmental delays to monkeys without containing thimerosal, but if so forgive me for unfairly changing the subject. But you may expect that I'll inadvertently do it again in the future, because my purposes are not limited in scope that way. I said it pages ago, and I'll say it again: It's not just the MMR, and it's not just autism. It's also not just mercury, and not just dystonia. |
||
|
|
|
|
|
#3 | |||||
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Quote:
Quote:
Quote:
Quote:
Quote:
"But numerous other studies show both are safe." "What? I don't care - it's really about all the vaccines and all the additives!" *sigh* then I suppose you won't bring up any more single-substance studies. |
|||||
|
|
|
|
|
#4 | |
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
People with money fund studies. By and large, this is pharmaceutical companies and equipment manufacturers. There are a lesser amount of public institutions that also fund studies, but they are usually hospitals and research facilities themselves that depend on the larger money from the pharmaceutical companies. And there are a handful of government agencies who are supposed to balance out the inherent bias that's going to be found in which studies get chosen by corporations. Usually they do a decent job of it, but they haven't been in this case. I suspect it's both because of the "means to an end" mentality I mentioned before, in addition to the fact that they are financially on the hook for billions of dollars if the hypothesis turns out to be true. Almost all autism research that focuses on environmental sources has been privately funded by very small donors--and almost always there is a child with autism in the family. If I'm ever a 'person with money' in the largesse sense of the word, you can bet I'll be funding studies left and right. But until then, I rely on public funding to do good science. Instead, they're paying people to sit in a room dissecting the auditory properties of newborns' crying. |
|
|
|
|
|
|
#5 |
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Can you just please point to those posts where I said how intelligent and logical I am. So I can apologize appropriately.
(Posts in which I point out illogic don't count.) |
|
|
|
|
|
#6 | |||
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
Quote:
Quote:
|
|||
|
|
|
|
|
#7 | ||
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Quote:
Quote:
|
||
|
|
|
|
|
#8 | |
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
|
|
|
|
|
|
|
#9 | ||
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Quote:
Quote:
|
||
|
|
|
|
|
#10 | |||||
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
Quote:
Quote:
Quote:
Quote:
|
|||||
|
|
|
|
|
#11 | ||||
|
Radical Centrist
Join Date: Jan 2001
Location: Cottage of Prussia
Posts: 31,423
|
Quote:
So: babies fighting off more stuff today? Or more 50 years ago, 100 years ago, 200 years ago? By the way, since we last talked about squalene, I've learned that the human body produces it normally, in the sebaceous glands. Quote:
Quote:
Quote:
|
||||
|
|
|
|
|
#12 | |
|
trying hard to be a better person
Join Date: Jan 2006
Location: Brisbane, Australia
Posts: 16,493
|
Quote:
__________________
Kind words are the music of the world. F. W. Faber |
|
|
|
|
|
|
#13 | ||
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
Quote:
My son is thrilled to be drinking his nasty-ass liquid formula all day long. You can hold out his favorite cookie and ask him if he wants it, and he will tell you no. Because he's not in pain anymore, and he's sharp enough to recognize what made him feel better. After only two weeks on the formula, he's suddenly starting to have honest-to-God conversations with me. Quote:
|
||
|
|
|
|
|
#14 | |
|
~~Life is either a daring adventure or nothing.~~
Join Date: Apr 2006
Posts: 6,828
|
Quote:
There are too many variables and too many levels of competency in individuals to lump all behaviors 'as attributed to pain.' I've seen a lot of head bangers. Kickers screamers and hair pullers. yes Some were in pain because their stomach hurt but most were just pissed because the tag in the back of the t shirt tickled too much or someone wore perfume or maybe the light was too bright or someone was making noise. And those are the bad behaviors. There are plenty of good behaviors too in association with autism and they are not gut related. [edit] I should say that these people had no verbal communication skills. Not having any verbal communication skills or the ability to convey wants and needs is very frustrating and leads to aggressive and SIB behavior. High functioning individuals have fewer episodes of aggression if behavior modification and training take place. A person who can self monitor their diet is even in a better place as far as positive behaviors but I've never seen a diet be the end all for a person/child with true autism. Behaviors is a large vague word. Behaviors are multi faceted and interconnected on so many physiological levels. I do agree that the stomach and intestines can be messed up and if curing/soothing/balancing that piece removes a child/person from the autism spectrum because all behaviors of that diagnosis no longer appear then that child never had autism to begin with. I do get and see where you are coming from but saying most behaviors are not neurological is disinformation. Last edited by skysidhe; 12-09-2009 at 07:20 PM. |
|
|
|
|
|
|
#15 |
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
I don't have access to any of the actual papers, but here is a complete list of cites regarding the autoimmune component of autism, and I bolded the ones that I would guess include examination of the over- or underactive attributes:
Ashwood P, Kwong C, Hansen R, Hertz-Picciotto I, Croen L, Krakowiak P, Walker W, Pessah IN, Van de Water J. Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype? J Autism Dev Disord. 2008 Jan;38(1):169-75. Ashwood P, et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004 Nov;24(6):664-73. Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun Rev. 2004 Nov;3(7-8):557-62. Ashwood P, et al. The immune response in autism: a new frontier for autism research. J Leuk Biol. 2006 Jul:80;1-15. Bayary J, et al. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol. 2006 Apr;6(4):528-34. Boris M, et al. Improvement in children treated with intravenous gamma globulin. J Nutr Environmental Med. Dec 2006; 15(4):1-8. Boris M, et al. Effect of Pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation. 2007 Jan 5;4:3. Bradstreet JJ, Smith S, Granpeesheh D, El-Dahr JM, Rossignol D. Spironolactone Might be a Desirable Immunologic and Hormonal Intervention in Autism Spectrum Disorders. Med Hypotheses. 2006 Dec 4. Brandtzaeg P. Current Understanding of Gastrointestinal Immunoregulation and Its Relation to Food Allergy. Ann NY Acad Sci. 2002;964:14-45. Braunschweig D, et al. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology. 2007 Nov 6. Bray TM, Taylor CG. Enhancement of tissue glutathione for antioxidant and immune functions in malnutrition. Biochem Pharmacol. 1994 Jun 15;47(12):2113-23. Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci. 2007 Jun;1107:92-103. Cave SF. The history of vaccinations in the light of the autism epidemic. Altern Ther Health Med. 2008 Nov-Dec;14(6):54-7. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferators-activated receptors (PPAR): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000;49:497-505. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol. 2005;71:317-41. Chmelik, E., N. Awadallah, et al. (2004). Varied presentation of PANDAS: a case series. Clin Pediatr (Phila) 43(4): 379-82. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr. 1999 May;134(5):607-13. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med. 2005 Feb;159(2):151-7. Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med. 2002 Nov;32(8):1457-63. Croonenberghs J, et al. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45(1):1-6. Cross ML. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int J Immunopathol Pharmacol. 2004 May-Aug;17(2):127-34. Dalton P, et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol. 2003 Apr;53(4):533-7. DelGiudice-Asch G, Simon L, Schmeidler J, Cunningham-Rundles C, Hollander E. Brief report: A pilot open clinical trial of intravenous immunoglobulin in childhood autism. J Autism Dev Disord. 1999:29(2):157-60. Denney DR, et al. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996 Feb;26(1):87-97. Dietert RR, Dietert JM. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.J Toxicol Environ Health B Crit Rev. 2008 Oct;11(8):660-80. Drakes M, Blanchard T, Czinn S. Bacterial probiotic modulation of dendritic cells. Infect Immun. 2004 Jun;72(6):3299-309. Droge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc. 2000 Nov;59(4):595-600. Elchaar GM, Maisch NM, Augusto LM, Wehring HJ. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Ann Pharmacother. 2006 Jun;40(6):1086-95. Engstrom HA, Ohlson S, Stubbs EG, Maciulis A, Caldwell V, Odell JD, Torres A.R. Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism. J Dev Phys Disabil. 2003 Jun 15;2:155-163(9). Ferrante P, Saresella M, Guerini FR, Marzorati M, Musetti MC, Cazzullo AG. Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed Pharmacother. 2003 Oct;57(8):372-4. Feinstein DL. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther. 2003;5(1):67-73. Fudenberg HH. Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study. Biotherapy. 1996;9(1-3):143-7. Furlano RI, et al. Autism and the immune system. J Child Psychol Psychiatry. 1997 Mar;38(3):337-49.Griem P., et al.; Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunology Today 19: 133-141, 1998. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008 Aug;29(8):357-65. Geier DA, Geier MR. A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders. Horm Res. 2006 Jul 5;66(4):182-188. Geier DA, Mumper E, Gladfelter B, Coleman L, Geier MR. Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment. Neuro Endocrinol Lett. 2008 Apr;29(2):272-80. Griem P, et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunology Today 19: 133-141, 1998. Gupta S. Immunological treatments for autism. J Autism Dev Disord. 2000 Oct;30(5):475-9. Gupta S, Aggarwal S, Heads C. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996 Aug;26(4):439-52. Gupta S, et al. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. 1998 May 1;85(1):106-9. Hamilton, RG, et al. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 114(2): 213-25. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):146-54. Jyonouchi H, et al. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr. 2005 May;146(5): 605-10. Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008 Nov 21;5(1):52. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune re-sponses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. 2001 Nov 1;120(1-2):170-9. Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002;46(2):76-84. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005;51(2):77-85. Kelly GS. Bovine colostrums: a review of clinical uses. Altern Med Rev. 2003 Nov;8(4):378-94. Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev. 2002 Dec;7(6):472-. Kirjavainen PV, et al. New aspects of probiotics--a novel approach in the management of food allergy. Allergy. 1999 Sep;54(9):909. Knickmeyer R, Baron-Cohen S, Raggatt P, Taylor K. Foetal testosterone, social relationships, and restricted interests in children. J Child Psychol Psychiatry. 2005 Feb;46(2):198-210. Konstantareas MM, Homatidis S. Ear infections in autistic and normal children. J Autism Dev Disord. 1987 Dec;17(4):585-94. Koski CL, Patterson JV. Intravenous immunoglobulin use for neurologic diseases. J Infus Nurs. 2006 May-Jun;29(3 Suppl):S21-8. |
|
|
|
![]() |
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
|
|